title: Rapidly Growing Chest Wall Mass in a Case of Sporadic Metastatic Paraganglioma: Imaging With 4 Different PET Radiopharmaceuticals.
abstract: Pheochromocytomas/paragangliomas (PGLs) are rare tumors and mostly benign. We report on a 32-year-old woman with metastatic PGL who was first diagnosed with an abdominal PGL at the age of 12 years. She soon developed metastatic disease and received several treatments including external beam radiation and chemotherapy. When she was referred to our institution in 2014, her major complaint was a rapidly growing chest wall mass on the left side. The patient was imaged at our institution with 4 different PET radiopharmaceuticals.
authors.affiliation: From the *Program in Adult and Reproductive Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, †Nuclear Medicine Division, Radiology and Imaging Sciences, Warren Grant Magnuson Clinical Center, and ‡Positron Emission Tomography Department, National Institutes of Health Clinical Center, National Institutes of Health; and §Center for Cancer Research, National Cancer Institute, Thoracic and Gastrointestinal Oncology Branch, Bethesda, MD.
authors.forename: Ingo
authors.initials: I
authors.lastname: Janssen
authors.forename: Paraskevi
authors.initials: P
authors.lastname: Xekouki
authors.forename: Joan
authors.initials: J
authors.lastname: Nambuba
authors.forename: Clara C
authors.initials: CC
authors.lastname: Chen
authors.forename: Peter
authors.initials: P
authors.lastname: Herscovitch
authors.forename: Corina M
authors.initials: CM
authors.lastname: Millo
authors.forename: David S
authors.initials: DS
authors.lastname: Schrump
authors.forename: Karel
authors.initials: K
authors.lastname: Pacak
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D010235:Paraganglioma / Q000000981:diagnostic imaging* / Q000473:pathology; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D035441:Thoracic Wall / Q000000981:diagnostic imaging* / Q000473:pathology
chemical_list: D019275:Radiopharmaceuticals
references.citation: Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1800-8
references.pmid: 24072345
references.citation: J Nucl Med. 2016 Feb;57(2):186-91
references.pmid: 26564322
references.citation: Mol Imaging Biol. 2011 Aug;13(4):769-75
references.pmid: 20700766
references.citation: Clin Cancer Res. 2015 Sep 1;21(17):3888-95
references.pmid: 25873086
references.citation: J Clin Endocrinol Metab. 2009 Dec;94(12):4757-67
references.pmid: 19864450
references.citation: Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):494-504
references.pmid: 24158184
references.citation: Nucl Med Mol Imaging. 2015 Jun;49(2):143-51
references.pmid: 26085860
references.citation: Eur J Nucl Med. 2001 Jul;28(7):836-46
references.pmid: 11504080
references.citation: Nucl Med Commun. 2007 May;28(5):359-63
references.pmid: 17414885
references.citation: Clin Endocrinol (Oxf). 2009 Jul;71(1):11-7
references.pmid: 19138315
references.citation: Int J Oncol. 2006 May;28(5):1249-61
references.pmid: 16596242
references.citation: Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1977-95
references.pmid: 22926712
references.citation: Eur J Nucl Med. 2000 Mar;27(3):273-82
references.pmid: 10774879
references.citation: J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42
references.pmid: 24893135
references.citation: J Clin Oncol. 2007 Jun 1;25(16):2262-9
references.pmid: 17538171